<?xml version="1.0" encoding="UTF-8"?>
<p>The most promising story from March and April was the initial efficacy of the antiviral drug Remdesivir. This drug is quite elegant in its approach to prevent RNA viruses from replicating. It is an adenosine analogue and is inserted into the strands of the viral RNA molecule, causing the premature termination of protein synthesis. It was supposed to be a cure for Ebola, but it did not show the desired efficacy against that disease [
 <xref rid="R33" ref-type="bibr">33</xref>].
</p>
